SinoMab Pty Ltd Report issue

For profit Phase 1 Phase 3
Founded: Australia (2001)

Organization Overview

First Clinical Trial
2012
NCT04704492
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

SinoMab Pty Ltd